Hyaluronidase (Ingredient)

Drugbank ID: DB06205
ATC code: B06AA03

The information below refers to products available in the United States that contain hyaluronidase.

Products containing hyaluronidase

hyaluronidase systemic

Brand names: Wydase, Amphadase, Hylenex, Vitrase, Hydase
Drug class: miscellaneous uncategorized agents

Hyaluronidase systemic is used in the treatment of:

• Dissolution of Dermal Filler
• Extravasation
• Hypodermoclysis
• Subcutaneous Urography

Multi-ingredient medications containing hyaluronidase

daratumumab/hyaluronidase systemic

Brand name: Darzalex Faspro
Drug class: CD38 monoclonal antibodies

Daratumumab/hyaluronidase systemic is used in the treatment of:

• Amyloidosis
• Multiple Myeloma

efgartigimod alfa/hyaluronidase systemic

Brand name: Vyvgart Hytrulo
Drug class: immune globulins

Efgartigimod alfa/hyaluronidase systemic is used in the treatment of:

• Chronic Inflammatory Demyelinating Polyradiculoneuropathy
• Myasthenia Gravis

hyaluronidase/immune globulin systemic

Brand name: Hyqvia
Drug class: immune globulins

Hyaluronidase/immune globulin systemic is used in the treatment of:

• Chronic Inflammatory Demyelinating Polyradiculoneuropathy
• Primary Immunodeficiency Syndrome

hyaluronidase/pertuzumab/trastuzumab systemic

Brand name: Phesgo
Drug class: HER2 inhibitors

Hyaluronidase/pertuzumab/trastuzumab systemic is used in the treatment of:

• Breast Cancer

hyaluronidase/rituximab systemic

Brand name: Rituxan Hycela
Drug class: CD20 monoclonal antibodies

Hyaluronidase/rituximab systemic is used in the treatment of:

• Chronic Lymphocytic Leukemia
• Diffuse Large B-Cell Lymphoma
• Follicular Lymphoma

hyaluronidase/trastuzumab systemic

Brand name: Herceptin Hylecta
Drug class: HER2 inhibitors

Hyaluronidase/trastuzumab systemic is used in the treatment of:

• Breast Cancer

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer